Skip to main content
Caplight Logo









Beijing Microread Genetics Co., Ltd.

Beijing Microread Genetics Co., Ltd.

Private
BeijingHealthcare & Life Scienceshttps://microread.com/index1/1.html

Last Round

IPO

Jun 27, 2022

Company Overview

Beijing Microread Genetics Co., Ltd. operates in Healthcare & Life Sciences and is based in Beijing. Its latest recorded funding round was a Series C round in December 2020.

Beijing Microread Genetics Co., Ltd. is a life sciences company that develops and manufactures genetic detection reagents and integrated solutions for forensic, clinical, and industrial applications.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, Medical Devices, Biotech Equipment, Precision Medicine

Business Model

B2B

Customer Profile

Hardware Sales, Usage-Based SaaS, Services & Consulting

AI Layer

Non-AI

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Pricing history

Caplight clients see full MarketPrice™ history and secondary transactions.

Book a demo

For institutional investors. Book with your work email.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

Momentum history

Caplight clients track how buyer interest and sentiment change over time.

Book a demo

For institutional investors. Book with your work email.

Beijing Microread Genetics Co., Ltd. Comparables

Compare Beijing Microread Genetics Co., Ltd. with similar companies based on industry and business-model similarity.

Beijing Microread Genetics Co., Ltd. comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
Peoplespot Technology (Beijing) Co., Ltd.
86%
Nanjing Superyears Gene Technology Co., Ltd.
86%
AGCU ScienTech Incorporation
85%
Book a demo to see all comparables

For institutional investors. Book with your work email.

Beijing Microread Genetics Co., Ltd. Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
IPOJun 27, 2022
Series CDec 30, 2020
VC RoundAug 1, 2020
VC RoundApr 1, 2019
Series BJan 20, 2017
Series A
Jan 7, 2016
Book a demo to see all funding rounds

For institutional investors. Book with your work email.

Key People

Founding team and executive leadership

Vincent H. G. Shu 許興國

CEO

Executive Team

For institutional investors. Book with your work email.

Beijing Microread Genetics Co., Ltd. Investors

Notable investors and investment history

Beijing Microread Genetics Co., Ltd. investors
InvestorRounds
Shenzhen Dachen Caizhi Venture Capital ManagementSeries A, VC Round
Suzhou New District Venture Capital GroupVC Round
HongShan Capital Group (HSG)Series C
Infore CapitalSeries C

Market signals

Structured signals derived from secondary market and firmographic data.

  • May 2, 2026

    Grew 16% QoQ, from 19 to 22 employees.

  • Apr 4, 2026

    Grew 21% QoQ from 19 to 23 employees.

Book a demo to see all signals

For institutional investors. Book with your work email.

Beijing Microread Genetics Co., Ltd. Filings

Explore SEC and related filing metadata, where available.

Beijing Microread Genetics Co., Ltd. filings preview — column headings only; records require access
TypeDateAmount OfferedAmount SoldFilingPagesDownload

Filing documents are not displayed on this public page. Request access to learn about available coverage.

Book a demo

For institutional investors. Book with your work email.

Frequently Asked Questions

Common questions about Beijing Microread Genetics Co., Ltd.'s valuation, stock price, and market status.

Is Beijing Microread Genetics Co., Ltd. a public or private company?

Beijing Microread Genetics Co., Ltd. is a private company.

What is the current stock price of Beijing Microread Genetics Co., Ltd.?

Beijing Microread Genetics Co., Ltd. is a private company, so its shares have no public market price. Caplight tracks Beijing Microread Genetics Co., Ltd.'s secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.

How much is Beijing Microread Genetics Co., Ltd. worth (valuation)?

Valuation information for Beijing Microread Genetics Co., Ltd. is not publicly available.

Can I buy Beijing Microread Genetics Co., Ltd. stock?

Beijing Microread Genetics Co., Ltd. shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.

When was Beijing Microread Genetics Co., Ltd.'s last funding round?

Beijing Microread Genetics Co., Ltd.'s most recent funding round was IPO on June 27, 2022.

Who are the main investors in Beijing Microread Genetics Co., Ltd.?

Key investors in Beijing Microread Genetics Co., Ltd. include HongShan Capital Group (HSG).

Will Beijing Microread Genetics Co., Ltd. IPO soon?

No public IPO plans have been announced for Beijing Microread Genetics Co., Ltd..

How can I track Beijing Microread Genetics Co., Ltd. secondary market activity?

Caplight tracks bids, offers, and trades in Beijing Microread Genetics Co., Ltd.'s shares on secondary markets.

Firmographic Details

HeadquartersBeijing
Employee Range23
Year Founded2009
Last FundingJun 27, 2022

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Book a demo

For institutional investors. Book with your work email.

See something wrong or outdated?